Sexual dysfunction in women with type 1 diabetes: long-term findings from the DCCT/ EDIC study cohort
- PMID: 19407075
- PMCID: PMC2671088
- DOI: 10.2337/dc08-1164
Sexual dysfunction in women with type 1 diabetes: long-term findings from the DCCT/ EDIC study cohort
Abstract
Objective: This study aimed to investigate the prevalence and risk factors associated with sexual dysfunction in a well-characterized cohort of women with type 1 diabetes.
Research design and methods: The study was conducted in women enrolled in the long-term Epidemiology of Diabetes Interventions and Complications (EDIC) study, a North American study of men and women with type 1 diabetes. At year 10 of the EDIC study, 652 female participants were invited to complete a validated self-report measure of sexual function, standardized history and physical examinations, laboratory testing, and mood assessment.
Results: Of the sexually active women with type 1 diabetes in the EDIC study, 35% met criteria for female sexual dysfunction (FSD). Women with FSD reported loss of libido (57%); problems with orgasm (51%), lubrication (47%), and arousal (38%); and pain (21%). Univariate analyses revealed a positive association between FSD and age (P = 0.0041), marital status (P = 0.0016), menopausal status (P = 0.0019), microvasculopathy (P = 0.0092), and depression (P = 0.0022). However, in a multivariate analysis, only depression (P = 0.004) and marital status (P = 0.003) were significant predictors of FSD.
Conclusions: FSD is common in women with type 1 diabetes and affects all aspects of sexual function and satisfaction. Depression is the major predictor of sexual dysfunction in women with type 1 diabetes. These findings suggest that women with type 1 diabetes should be routinely queried about the presence of sexual dysfunction and possible co-association with depression.
Comment in
-
Sexual dysfunction in women with type 1 diabetes: long-term findings from the DCCT/EDIC study cohort: response to Enzlin et al.Diabetes Care. 2010 Jan;33(1):e19. doi: 10.2337/dc09-0910. Diabetes Care. 2010. PMID: 20040669 No abstract available.
References
-
- Brown JS, Wessells H, Chancellor MB, Howards SS, Stamm WE, Stapleton AE, Steers WD, Van Den Eeden SK, McVary KT: Urologic complications of diabetes. Diabetes Care 2005; 28: 177– 185 - PubMed
-
- Rosen RC, Wing R, Schneider S, Gendrano N, 3rd: Epidemiology of erectile dysfunction: the role of medical comorbidities and lifestyle factors. Urol Clin North Am 2005; 32: 403– 417 - PubMed
-
- Lauman E, Paik B, Rosen R: Sexual dysfunction in the United States: prevalence, predictors and outcomes. JAMA 1999; 281: 537– 544 - PubMed
-
- Fedele D, Bortolotti A, Coscelli C, Santeusanio F, Chatenoud L, Colli E, Lavezzari M, Landoni M, Parazzini F: on behalf of Gruppo Italiano Studio Deficit Erettile nei Diabetici. Erectile dysfunction in type 1 and type 2 diabetics in Italy. Int J Epidemiol 2000; 29: 524– 531 - PubMed
-
- Rhodenet EL, Ribeiro EP, Riedner CE, Teloken C, Souto CA: Glycosylated haemoglobin levels and the severity of erectile function in diabetic men. BJU Int 2005; 95: 615– 617 - PubMed
